✦ LIBER ✦

ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma

✍ Scribed by Massimo Offidani; Pietro Leoni; Laura Corvatta; Claudia Polloni; Silvia Gentili; Agnese Savini; Francesco Alesiani; Marino Brunori; Massimo Catarini; Giuseppe Visani; Arduino Samori; Maurizio Burattini; Riccardo Centurioni; Mauro Montanari; Paolo Fraticelli; Miriana Ruggieri; Sadia Falcioni; Piero Galieni

Book ID: 114794743
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 258 KB
Volume: 84
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2010.01418.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose therapy and autologous periphe

High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients

✍ Massimo Martino; Giuseppe Console; Giuseppe Irrera; Giulia Praticò; Caterina Ste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

## Abstract The recent development of reduced intensity conditioning and allotransplantation (RICT) has opened a new way to assure engraftment of donor cells while reducing early transplant‐related mortality. We evaluated the combination of high‐dose therapy and autologous peripheral blood stem cel